Healthtech Solutions Inc. (HLTT)
Healthtech Solutions Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Tuckahoe, NY, US. The stock last traded at $0.00, down 0.00% on the session, giving a market capitalisation of $10,663. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -180.3%. Its beta of 1.95 implies it has historically moved more than the broad market.
Healthtech Solutions Inc. operates as a life sciences firm through its various subsidiary companies. A primary area of their work involves creating innovative products for the treatment of both acute and chronic wounds, exemplified by AmnioBind. This specific offering is a placental membrane allograft designed to address severe burns and persistent wounds, such as diabetic foot ulcers. Beyond wound care, the company is also engaged in developing advanced ultrasound imaging technology that integrates artificial intelligence for image analysis, intended for applications in diagnosing and treating conditions affecting the chest and musculoskeletal system. Furthermore, Healthtech Solutions is pioneering software designed to electronically compare signals from a healthy heart rhythm with those from a damaged heart, aiming to derive a unique "curative waveform" signal. Established in 2018, the company's headquarters are located in Tuckahoe, New York.
Healthtech Solutions Inc. is most often compared with the following Healthcare names: